{'52WeekChange': -0.49838185,
 'SandP52WeekChange': 0.0644362,
 'address1': '525 Executive Boulevard',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.56,
 'askSize': 1000,
 'averageDailyVolume10Day': 58262,
 'averageVolume': 128217,
 'averageVolume10days': 58262,
 'beta': 0.070028,
 'beta3Year': None,
 'bid': 1.54,
 'bidSize': 1000,
 'bookValue': 0.065,
 'category': None,
 'circulatingSupply': None,
 'city': 'Elmsford',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.62,
 'dayLow': 1.53,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.114,
 'enterpriseToRevenue': 21.12,
 'enterpriseValue': 11932706,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '914 376 6111',
 'fiftyDayAverage': 2.0422287,
 'fiftyTwoWeekHigh': 3.5,
 'fiftyTwoWeekLow': 1.32,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 3444771,
 'forwardEps': -0.81,
 'forwardPE': -1.9382716,
 'fromCurrency': None,
 'fullTimeEmployees': 10,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.11192001,
 'heldPercentInstitutions': 0.36171,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/nanovibronix.com',
 'longBusinessSummary': 'NanoVibronix, Inc., through its subsidiary, '
                        'NanoVibronix Ltd., focuses on the manufacture and '
                        'sale of noninvasive biological response-activating '
                        'devices that target biofilm prevention, wound '
                        'healing, and pain therapy. Its principal products '
                        'include UroShield, an ultrasound-based product to '
                        'prevent bacterial colonization and biofilm in urinary '
                        'catheters, enhance antibiotic efficacy, and decrease '
                        'pain and discomfort associated with urinary catheter '
                        'use; PainShield, a patch-based therapeutic ultrasound '
                        'technology to treat pain, muscle spasm, and joint '
                        'contractures; and WoundShield, a patch-based '
                        'therapeutic ultrasound device, which facilitates '
                        'tissue regeneration and wound healing. The company '
                        'sells its products directly to patients, as well as '
                        'through distributor agreements in the United States, '
                        'Israel, Europe, India, and internationally. '
                        'NanoVibronix, Inc. was founded in 2003 and is based '
                        'in Elmsford, New York.',
 'longName': 'NanoVibronix, Inc.',
 'market': 'us_market',
 'marketCap': 7243603,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_27619235',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -4036000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.6,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '914 233 3004',
 'previousClose': 1.57,
 'priceHint': 4,
 'priceToBook': 24.153849,
 'priceToSalesTrailing12Months': 12.820537,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.62,
 'regularMarketDayLow': 1.53,
 'regularMarketOpen': 1.6,
 'regularMarketPreviousClose': 1.57,
 'regularMarketPrice': 1.6,
 'regularMarketVolume': 26556,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 4613760,
 'sharesPercentSharesOut': 0.0017,
 'sharesShort': 7363,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 7047,
 'shortName': 'NanoVibronix, Inc.',
 'shortPercentOfFloat': 0.0017,
 'shortRatio': 3.69,
 'startDate': None,
 'state': 'NY',
 'strikePrice': None,
 'symbol': 'NAOV',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.569,
 'twoHundredDayAverage': 2.325698,
 'volume': 26556,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.nanovibronix.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '10523'}